Causal association between iron status and heart failure: A 2-sample bidirectional Mendelian randomization study

Yaqi Hu1, Tao He2, Jianhe Liu2

  • 1National Chinese Medicine Master Sun Guangrong Studio, Hunan Academy of Chinese Medicine, Changsha, Hunan, China.

Medicine
|November 8, 2025
PubMed

Observational studies have shown that serum iron status is related to heart failure (HF). However, due to confounding factors and reverse causation, there is still controversy over whether this association is causal. Our aim is to assess the causal relationship between genetically predicted serum iron status and HF. This study uses inverse variance weighting as the main method for Mendelian Randomization (MR) analysis, while also employing MR-Egger and weighted median as supplementary methods to evaluate the causal relationship between exposure factors and outcome variables. Additionally, the MR-Egger intercept test and MR-pleiotropy residual sum and outliers (MR-PRESSO) test were employed to assess the horizontal pleiotropy and outlier single nucleotide polymorphism. Cochran Q test in MR-Egger and inverse variance weighting methods was performed to evaluate the heterogeneity among the single nucleotide polymorphisms, and sensitivity analysis was performed by using the"leave-one-out"method. Finally, reverse MR analysis was used to verify the robustness of the results. Elevated serum ferritin levels (OR = 1.147, 95% CI 1.014-1.298, P-value = .029) have a causal relationship with a reduced risk of HF. However, there is no potential genetic causal relationship between serum iron, total iron-binding capacity, and transferrin saturation and HF (P >.05). In the reverse MR analysis, none of the 3 methods support reverse causality. The intercept test of the MR-Egger regression model, the MR-PRESSO test, and Cochran Q test all have P-values >.05, indicating that the selected single nucleotide polymorphisms do not exhibit horizontal pleiotropy or heterogeneity. In addition, the sensitivity analysis based on the leave-one-out method shows that a single single nucleotide polymorphism does not affect the robustness of the causal association effect value. There is a causal relationship between genetically predicted serum ferritin levels and the risk of HF, indicating that high levels of serum ferritin may be a protective factor against HF.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
868
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
305